YAP1 and cancer: Despite this, the anti-cancer activity of YAP/TAZ in YAPoff liquid cancers can largely be explained by TEAD-independent mechanisms, which are, at least in part, due to the unique cellular context of these tumors (e.g., high nuclear ABL1 levels [36]).